Dynavax Technologies Corp [NASDAQ: DVAX] closed the trading session at $12.62.
The stocks have a year to date performance of -1.17 percent and weekly performance of -1.17 percent. The stock has been moved at 19.06 percent over the last six months. The stock has performed -1.79 percent around the most recent 30 days and changed 18.72 percent over the most recent 3-months.
If compared to the average trading volume of 2.14M shares, DVAX reached to a volume of 5148818 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Dynavax Technologies Corp [DVAX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DVAX shares is $23.80 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DVAX stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Dynavax Technologies Corp shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 01, 2024. While these analysts kept the previous recommendation, JMP Securities raised their target price to Mkt Outperform. The new note on the price target was released on September 27, 2022, representing the official price target for Dynavax Technologies Corp stock. Previously, the target price had yet another raise to $38, while Goldman analysts kept a Buy rating on DVAX stock.
The Average True Range (ATR) for Dynavax Technologies Corp is set at 0.34, with the Price to Sales ratio for DVAX stock in the period of the last 12 months amounting to 6.36. The Price to Book ratio for the last quarter was 2.43, with the Price to Cash per share for the same quarter was set at 5.81. Price to Free Cash Flow for DVAX in the course of the last twelve months was 73.18 with Quick ratio for the last quarter at 12.34.
DVAX stock trade performance evaluation
Dynavax Technologies Corp [DVAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.17. With this latest performance, DVAX shares dropped by -1.79% in over the last four-week period, additionally plugging by 19.06% over the last 6 months – not to mention a drop of -9.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DVAX stock in for the last two-week period is set at 45.69, with the RSI for the last a single of trading hit 39.12, and the three-weeks RSI is set at 49.75 for Dynavax Technologies Corp [DVAX]. The present Moving Average for the last 50 days of trading for this stock 12.64, while it was recorded at 12.81 for the last single week of trading, and 11.63 for the last 200 days.
Dynavax Technologies Corp [DVAX]: An insightful look at the core fundamentals
Dynavax Technologies Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 12.34 and a Current Ratio set at 13.23.
Dynavax Technologies Corp [DVAX]: Institutional Ownership
There are presently around $104.91%, or 105.26%% of DVAX stock, in the hands of institutional investors. The top three institutional holders of DVAX stocks are: BLACKROCK INC. with ownership of 21.9 million shares, which is approximately 16.7308%. DEEP TRACK CAPITAL, LP, holding 10.9 million shares of the stock with an approximate value of $$122.41 million in DVAX stocks shares; and DEEP TRACK CAPITAL, LP, currently with $$105.26 million in DVAX stock with ownership which is approximately 7.1594%.
